Literature DB >> 21800116

Pulmonary alveolar proteinosis as an unusual pattern of lung involvement in Sjögren syndrome.

Eugene Park1, Hae-Rim Kim, Hee Joung Kim, Sang-Heon Lee.   

Abstract

Primary Sjögren syndrome (pSS) is an autoimmune disease that is characterized by infiltration of lymphocytes in exocrine glands, followed by hypofunction of the glands. Dry mouth and eyes are main symptoms, but there are various extraglandular manifestations in pSS. Nine to 75% of patients have pulmonary involvement such as interstitial lung diseases. Pulmonary alveolar proteinosis (PAP) is also a kind of autoimmune disorder, characterized by the presence of anti-granulocyte/macrophage colony-stimulating factor antibody. A 45-year-old nonsmoking woman was admitted with dyspnea and dry cough. She was diagnosed as having PAP, based on characteristic computed tomography, bronchoalveolar lavage, and lung biopsy findings. At the same time, she was diagnosed with pSS, based on dry mouth, xerophthalmia, positive anti-Ro/La antibodies, and scintigraphic finding of salivary glands. Whole lung lavages and monthly intravenous cyclophosphamide had slight improvement in PAP.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21800116     DOI: 10.1007/s00296-011-2001-0

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  21 in total

Review 1.  Pulmonary alveolar proteinosis.

Authors:  Bruce C Trapnell; Jeffrey A Whitsett; Koh Nakata
Journal:  N Engl J Med       Date:  2003-12-25       Impact factor: 91.245

2.  Pulmonary alveolar proteinosis and cytomegalovirus infection.

Authors:  M Ranchod; M Bissell
Journal:  Arch Pathol Lab Med       Date:  1979-03       Impact factor: 5.534

3.  Clinical follow up study of 87 patients with sicca symptoms (dryness of eyes or mouth, or both).

Authors:  M Pertovaara; M Korpela; H Uusitalo; J Pukander; A Miettinen; H Helin; A Pasternack
Journal:  Ann Rheum Dis       Date:  1999-07       Impact factor: 19.103

4.  Primary cerebellar nocardiosis and alveolar proteinosis.

Authors:  W G Oerlemans; E N Jansen; R L Prevo; M M Eijsvogel
Journal:  Acta Neurol Scand       Date:  1998-02       Impact factor: 3.209

5.  GM-CSF enhances lung growth and causes alveolar type II epithelial cell hyperplasia in transgenic mice.

Authors:  J A Huffman Reed; W R Rice; Z K Zsengellér; S E Wert; G Dranoff; J A Whitsett
Journal:  Am J Physiol       Date:  1997-10

6.  Granulocyte/macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology.

Authors:  E Stanley; G J Lieschke; D Grail; D Metcalf; G Hodgson; J A Gall; D W Maher; J Cebon; V Sinickas; A R Dunn
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-07       Impact factor: 11.205

7.  Pulmonary alveolar proteinosis: its association with hematologic malignancy and lymphoma.

Authors:  R Carnovale; J Zornoza; A M Goldman; M Luna
Journal:  Radiology       Date:  1977-02       Impact factor: 11.105

8.  Recurrent pulmonary alveolar proteinosis secondary to agammaglobulinemia.

Authors:  Türkan Patiroglu; Başak Akyildiz; Tahir E Patiroglu; Inci Y Gulmez
Journal:  Pediatr Pulmonol       Date:  2008-07

Review 9.  Primary Sjögren's syndrome--clinical and laboratory markers of disease activity.

Authors:  P Oxholm
Journal:  Semin Arthritis Rheum       Date:  1992-10       Impact factor: 5.532

Review 10.  Pulmonary alveolar proteinosis: progress in the first 44 years.

Authors:  John F Seymour; Jeffrey J Presneill
Journal:  Am J Respir Crit Care Med       Date:  2002-07-15       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.